Outpatient left ventricular assist device support

A destination rather than a bridge

Katharine A. Catanese, Daniel J. Goldstein, Deborah L. Williams, Ann T. Foray, Christopher D. Illick, Michael T. Gardocki, Alan D. Weinberg, Howard R. Levin, Eric A. Rose, Mehmet C. Oz

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Background. To evaluate the feasibility and efficacy of outpatient left ventricular assist devices as a bridge to transplantation, we reviewed the initial clinical experience with this modality at our institution. Methods. During January 1993 to November 1995, 12 male and 2 female patients with an average age of 47 ± 17 years were supported for an average of 117 ± 24 days with the Thermo Cardiosystems VE wearable left ventricular assist device. Seven patients were discharged home an average of 33 ± 4 days after implantation. Results. No device failures occurred, although 29 controller malfunctions were identified during 1,640 total support days. All patients were able to safely maintain their devices. Outflow graft bleeding and driveline infection were responsible for two readmissions. No long-term anticoagulation treatment was used; one small thromboembolic episode occurred, but without significant long-term sequelae. Conclusions. None of the 7 patients released from the hospital died, and all were able to successfully maintain their devices at home. Hospital discharge of patients supported with left ventricular assist devices has allowed long-term evaluation of this technology, and the findings should prompt study of their use as a long-term alternative treatment to medical management for congestive heart failure.

Original languageEnglish (US)
Pages (from-to)646-653
Number of pages8
JournalAnnals of Thoracic Surgery
Volume62
Issue number3
DOIs
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

Heart-Assist Devices
Outpatients
Equipment Failure
Equipment and Supplies
Patient Discharge
Heart Failure
Transplantation
Hemorrhage
Technology
Transplants
Therapeutics
Infection

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Catanese, K. A., Goldstein, D. J., Williams, D. L., Foray, A. T., Illick, C. D., Gardocki, M. T., ... Oz, M. C. (1996). Outpatient left ventricular assist device support: A destination rather than a bridge. Annals of Thoracic Surgery, 62(3), 646-653. https://doi.org/10.1016/S0003-4975(96)00456-0

Outpatient left ventricular assist device support : A destination rather than a bridge. / Catanese, Katharine A.; Goldstein, Daniel J.; Williams, Deborah L.; Foray, Ann T.; Illick, Christopher D.; Gardocki, Michael T.; Weinberg, Alan D.; Levin, Howard R.; Rose, Eric A.; Oz, Mehmet C.

In: Annals of Thoracic Surgery, Vol. 62, No. 3, 09.1996, p. 646-653.

Research output: Contribution to journalArticle

Catanese, KA, Goldstein, DJ, Williams, DL, Foray, AT, Illick, CD, Gardocki, MT, Weinberg, AD, Levin, HR, Rose, EA & Oz, MC 1996, 'Outpatient left ventricular assist device support: A destination rather than a bridge', Annals of Thoracic Surgery, vol. 62, no. 3, pp. 646-653. https://doi.org/10.1016/S0003-4975(96)00456-0
Catanese, Katharine A. ; Goldstein, Daniel J. ; Williams, Deborah L. ; Foray, Ann T. ; Illick, Christopher D. ; Gardocki, Michael T. ; Weinberg, Alan D. ; Levin, Howard R. ; Rose, Eric A. ; Oz, Mehmet C. / Outpatient left ventricular assist device support : A destination rather than a bridge. In: Annals of Thoracic Surgery. 1996 ; Vol. 62, No. 3. pp. 646-653.
@article{43db3ce52f894ef58a6951daacd6ed0e,
title = "Outpatient left ventricular assist device support: A destination rather than a bridge",
abstract = "Background. To evaluate the feasibility and efficacy of outpatient left ventricular assist devices as a bridge to transplantation, we reviewed the initial clinical experience with this modality at our institution. Methods. During January 1993 to November 1995, 12 male and 2 female patients with an average age of 47 ± 17 years were supported for an average of 117 ± 24 days with the Thermo Cardiosystems VE wearable left ventricular assist device. Seven patients were discharged home an average of 33 ± 4 days after implantation. Results. No device failures occurred, although 29 controller malfunctions were identified during 1,640 total support days. All patients were able to safely maintain their devices. Outflow graft bleeding and driveline infection were responsible for two readmissions. No long-term anticoagulation treatment was used; one small thromboembolic episode occurred, but without significant long-term sequelae. Conclusions. None of the 7 patients released from the hospital died, and all were able to successfully maintain their devices at home. Hospital discharge of patients supported with left ventricular assist devices has allowed long-term evaluation of this technology, and the findings should prompt study of their use as a long-term alternative treatment to medical management for congestive heart failure.",
author = "Catanese, {Katharine A.} and Goldstein, {Daniel J.} and Williams, {Deborah L.} and Foray, {Ann T.} and Illick, {Christopher D.} and Gardocki, {Michael T.} and Weinberg, {Alan D.} and Levin, {Howard R.} and Rose, {Eric A.} and Oz, {Mehmet C.}",
year = "1996",
month = "9",
doi = "10.1016/S0003-4975(96)00456-0",
language = "English (US)",
volume = "62",
pages = "646--653",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Outpatient left ventricular assist device support

T2 - A destination rather than a bridge

AU - Catanese, Katharine A.

AU - Goldstein, Daniel J.

AU - Williams, Deborah L.

AU - Foray, Ann T.

AU - Illick, Christopher D.

AU - Gardocki, Michael T.

AU - Weinberg, Alan D.

AU - Levin, Howard R.

AU - Rose, Eric A.

AU - Oz, Mehmet C.

PY - 1996/9

Y1 - 1996/9

N2 - Background. To evaluate the feasibility and efficacy of outpatient left ventricular assist devices as a bridge to transplantation, we reviewed the initial clinical experience with this modality at our institution. Methods. During January 1993 to November 1995, 12 male and 2 female patients with an average age of 47 ± 17 years were supported for an average of 117 ± 24 days with the Thermo Cardiosystems VE wearable left ventricular assist device. Seven patients were discharged home an average of 33 ± 4 days after implantation. Results. No device failures occurred, although 29 controller malfunctions were identified during 1,640 total support days. All patients were able to safely maintain their devices. Outflow graft bleeding and driveline infection were responsible for two readmissions. No long-term anticoagulation treatment was used; one small thromboembolic episode occurred, but without significant long-term sequelae. Conclusions. None of the 7 patients released from the hospital died, and all were able to successfully maintain their devices at home. Hospital discharge of patients supported with left ventricular assist devices has allowed long-term evaluation of this technology, and the findings should prompt study of their use as a long-term alternative treatment to medical management for congestive heart failure.

AB - Background. To evaluate the feasibility and efficacy of outpatient left ventricular assist devices as a bridge to transplantation, we reviewed the initial clinical experience with this modality at our institution. Methods. During January 1993 to November 1995, 12 male and 2 female patients with an average age of 47 ± 17 years were supported for an average of 117 ± 24 days with the Thermo Cardiosystems VE wearable left ventricular assist device. Seven patients were discharged home an average of 33 ± 4 days after implantation. Results. No device failures occurred, although 29 controller malfunctions were identified during 1,640 total support days. All patients were able to safely maintain their devices. Outflow graft bleeding and driveline infection were responsible for two readmissions. No long-term anticoagulation treatment was used; one small thromboembolic episode occurred, but without significant long-term sequelae. Conclusions. None of the 7 patients released from the hospital died, and all were able to successfully maintain their devices at home. Hospital discharge of patients supported with left ventricular assist devices has allowed long-term evaluation of this technology, and the findings should prompt study of their use as a long-term alternative treatment to medical management for congestive heart failure.

UR - http://www.scopus.com/inward/record.url?scp=0030248076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030248076&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(96)00456-0

DO - 10.1016/S0003-4975(96)00456-0

M3 - Article

VL - 62

SP - 646

EP - 653

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -